Clinical trial
Change of Dopamine Pathway After rTMS Treatment in Major Depressive Disorder
NCT01325831 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Change of Dopamine Pathway After rTMS Treatment in Major Depressive Disorder
- Lead sponsor
- Yonsei University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- June 30, 2011
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
major depression